ARCHIVES

Hammer Says He’ll Demand Construction Funds If Data Supports The Need

This article is from The Cancer Letter archive.

Vol. 09 No. 32 | August 12, 1983

Download PDF Visit The Full Archive

Related Articles

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

May 2, 2008

SAIC Frederick Offers Use Of Drug Facility

August 4, 1995

Funding For Groups, Working With Industry, Still Unresolved

June 12, 1998

Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee

November 16, 1979

FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma

August 30, 2013

Tests Find No Conclusive Evidence On Two Chemicals

September 21, 1979